Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2025-07-02

FDA Approved: WARFARIN SODIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Warfarin Sodium by Teva Pharmaceuticals USA, Inc., resulting in changes to the product labeling. This action constit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • WARFARIN SODIUM (Warfarin sodium)

Snippet

SUPPL AP for WARFARIN SODIUM (WARFARIN SODIUM)